BIOXCEL THERAPEUTICS INC's ticker is and the CUSIP is 09075P905. A total of 4 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,468 | -97.9% | 15,600 | -94.5% | 0.00% | -100.0% |
| Q2 2023 | $1,891,440 | +2372.3% | 284,000 | +6826.8% | 0.01% | – |
| Q1 2023 | $76,506 | -72.6% | 4,100 | -68.5% | 0.00% | -100.0% |
| Q4 2022 | $279,240 | -43.5% | 13,000 | -68.9% | 0.00% | 0.0% |
| Q3 2022 | $494,000 | +233.8% | 41,800 | +273.2% | 0.00% | – |
| Q2 2022 | $148,000 | -27.1% | 11,200 | +15.5% | 0.00% | – |
| Q1 2022 | $203,000 | -81.3% | 9,700 | -81.8% | 0.00% | -100.0% |
| Q4 2021 | $1,084,000 | +325.1% | 53,300 | +534.5% | 0.00% | – |
| Q3 2021 | $255,000 | -18.0% | 8,400 | -21.5% | 0.00% | – |
| Q2 2021 | $311,000 | +85.1% | 10,700 | +174.4% | 0.00% | – |
| Q1 2021 | $168,000 | -87.5% | 3,900 | -86.6% | 0.00% | -100.0% |
| Q4 2020 | $1,344,000 | +18.7% | 29,100 | +11.5% | 0.00% | -50.0% |
| Q3 2020 | $1,132,000 | -1.6% | 26,100 | +20.3% | 0.00% | -20.0% |
| Q2 2020 | $1,150,000 | +1374.4% | 21,700 | +520.0% | 0.01% | +400.0% |
| Q1 2020 | $78,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 158 | $730,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 29,100 | $1,344,000 | 0.00% |
| SIMPLEX TRADING, LLC | 26 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |